COVID-19 and mucormycosis in Latin America - An emerging concern.
作者信息
Rodriguez-Morales Alfonso J, Mamani-García Carlos S, Nuñez-Lupaca Janeth N, León-Figueroa Darwin A, Olarte-Durand Mely, Yrene-Cubas Robinson A, Ticona Diana M, Abanto-Urbano Sebastian
机构信息
Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, Colombia; Master of Clinical Epidemiology and Biostatistics, Universidad Cientifica del Sur, Lima, Peru; School of Medicine, Universidad Privada Franz Tamayo (UNIFRANZ), Cochabamba, Bolivia.
Facultad de Medicina Humana, Universidad Nacional de San Agustín de Arequipa, Arequipa, Peru; Sociedad Científica de Estudiantes de Medicina Agustinos (SOCIEMA), Arequipa, Peru.
出版信息
Travel Med Infect Dis. 2021 Nov-Dec;44:102156. doi: 10.1016/j.tmaid.2021.102156. Epub 2021 Aug 25.
Abstract
摘要
相似文献
1
COVID-19 and mucormycosis in Latin America - An emerging concern.
Travel Med Infect Dis. 2021 Nov-Dec;44:102156. doi: 10.1016/j.tmaid.2021.102156. Epub 2021 Aug 25.
2
Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum.
Int J Surg. 2021 Aug;92:106031. doi: 10.1016/j.ijsu.2021.106031. Epub 2021 Jul 24.
3
COVID-19-associated mucormycosis: an epidemic within a pandemic.
QJM. 2021 Oct 7;114(6):355-356. doi: 10.1093/qjmed/hcab165.
4
Mucormycosis: An unanticipated progeny of COVID-19.
JNMA J Nepal Med Assoc. 2021 Sep 11;59(241):965-967. doi: 10.31729/jnma.6686.
5
Commentary on "Mucormycosis co-infection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum" (Int J Surg 2021, 92:106031) - A pulmonary perspective.
Int J Surg. 2021 Oct;94:106116. doi: 10.1016/j.ijsu.2021.106116. Epub 2021 Sep 17.
6
Mucormycosis-A serious threat in the COVID-19 pandemic?
J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.05.015. Epub 2021 May 21.
7
Fostering a deeper understanding of COVID-19-associated mucormycosis - A commentary on "The mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum" (Int. J. Surg. 2021:106031).
Int J Surg. 2021 Oct;94:106110. doi: 10.1016/j.ijsu.2021.106110. Epub 2021 Sep 14.
8
In-hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID-19) patients and COVID-19 in mucormycosis: a systematic review and meta-analysis.
Int Forum Allergy Rhinol. 2022 Mar;12(3):313-317. doi: 10.1002/alr.22906. Epub 2021 Oct 11.
9
[Fungal infections in the COVID-19 pandemic, the case of mucormycosis].
Rev Argent Microbiol. 2021 Jul-Sep;53(3):181-182. doi: 10.1016/j.ram.2021.09.001.
10
Mucormycosis in COVID-19 patients.
Indian J Ophthalmol. 2021 Dec;69(12):3728-3733. doi: 10.4103/ijo.IJO_1316_21.
引用本文的文献
1
Polymicrobial infection including Mucormycosis in a patient with COVID-19: A case report.
IDCases. 2025 Jun 9;41:e02282. doi: 10.1016/j.idcr.2025.e02282. eCollection 2025.
2
Mucormycosis and COVID-19: Unraveling the Interplay of Fungal Infection in a Global Health Crisis: An Overview.
Infect Disord Drug Targets. 2025;25(4):e18715265310191. doi: 10.2174/0118715265310191240919060621.
3
Oral mucormycosis associated with COVID-19 and diabetes mellitus: Case report and literature review.
Biomedica. 2024 Mar 31;44(1):10-15. doi: 10.7705/biomedica.6970.
4
COVID-19, mucormycosis, and the cow: Damned lies!
Indian J Med Microbiol. 2023 Jul-Aug;44:100382. doi: 10.1016/j.ijmmb.2023.100382. Epub 2023 May 24.
5
Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review.
Diagnostics (Basel). 2022 Dec 8;12(12):3092. doi: 10.3390/diagnostics12123092.
6
COVID 19 and febrile neutropenia: Case report and systematic review.
Travel Med Infect Dis. 2022 May-Jun;47:102305. doi: 10.1016/j.tmaid.2022.102305. Epub 2022 Mar 7.
本文引用的文献
1
COVID-19-associated mucormycosis: Case report and systematic review.
Travel Med Infect Dis. 2021 Nov-Dec;44:102148. doi: 10.1016/j.tmaid.2021.102148. Epub 2021 Aug 26.
2
COVID-19 Associated Rhino-Orbital Mucormycosis Complicated by Gangrenous and Bone Necrosis-A Case Report from Honduras.
Vaccines (Basel). 2021 Jul 27;9(8):826. doi: 10.3390/vaccines9080826.
3
Mucormycosis after COVID-19 in a patient with diabetes.
Lancet. 2021 Aug 21;398(10301):e10. doi: 10.1016/S0140-6736(21)01641-X. Epub 2021 Aug 4.
4
Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.
Rev Soc Bras Med Trop. 2021 Jul 12;54:e03582021. doi: 10.1590/0037-8682-0358-2021. eCollection 2021.
5
Mucormycosis and COVID-19: An epidemic within a pandemic in India.
Mycoses. 2021 Oct;64(10):1253-1260. doi: 10.1111/myc.13353. Epub 2021 Jul 24.
6
Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102196. doi: 10.1016/j.dsx.2021.102196. Epub 2021 Jul 3.
7
Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.
Mymensingh Med J. 2021 Jul;30(3):874-880.
8
Rare case of gastrointestinal mucormycosis with colonic perforation in an immunocompetent patient with COVID-19.
BMJ Case Rep. 2021 Jul 2;14(7):e244096. doi: 10.1136/bcr-2021-244096.
9
COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs.
Ther Adv Infect Dis. 2021 Jun 18;8:20499361211027065. doi: 10.1177/20499361211027065. eCollection 2021 Jan-Dec.
10
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
Zotero 插件